Ilker Kanzik, PhD is the Co-founder and Managing Director of IDEAL Pharma Consulting. Prior to founding IDEAL Pharma Consulting, Dr. Kanzik was also a co-founder of another consulting company which mainly dealed with regulatory affairs and organizing bioequivalence studies for both local and foreign pharmaceutical (original or generic) companies as the managing partner for over 15 years.

Dr Kanzik is a professor in Pharmacology. His biomedical research experience covers a broad-range of therapeutic areas including cardiopulmonary disorders, gastrointestinal, neurology, oncology, pharmacogenetics and biopharmaceutics and includes work on both biologics and drugs.

Throughout his 40-year academic career, he held several positions at every level. He is author of ‘Textbook of Pharmacology’ (in Turkish) and author (or co-author) of over 100 scientific articles (research papers, reviews and abstracts) and participation at several Textbooks. He has over 150 presentations in both international and national meetings.

His recent area of interest includes organising clinical trials and bioanalysis for bioavalibility and bioequivalence studies, comparability studies for biopharmaceluticals and regulatory affairs.

Previously he was a member of Pharmaceutical Assessment of the Medicines Evaluation Board in Ministry of Health (MoH), Turkey, and was scientific consultant to both MoH and Turkish Pharmaceutical Manufacturers’ Association. He is at present a member of several professional associations and Scientific Advisory Board of Association of Research-Based Pharmaceutical Companies.

Selma Koru, Pharm. M.Sc. is the Co-founder and Technical Manager of IDEAL Pharma Consulting. Prior to founding IDEAL Pharma Consulting, Koru was the Bioequivalence Project Manager of another consulting company which mainly dealed with regulatory affairs and organizing bioequivalence studies for both local and foreign pharmaceutical (original or generic) companies for over 10 years with approximately 350 projects experience.

Koru is graduated from the Gazi University Faculty of Pharmacy, Ankara in 2002 and completed her Master in 2005 in the Pharmacology Department of the same Faculty. After one year of Pharmacy experience she was dealing with clinical trials and especially bioequivalence studies for more than 10 years as a CRA, Project Assistant and finally Project Manager.

Her recent area of interest includes the regulative requirements for organising clinical trials and bioanalysis for bioavalibility and bioequivalence studies, comparability studies for biopharmaceluticals.

She is a member of Clinical Trials Association since 2009. She has GCP certificate from Vienna School of Clinical Research.

Koru is good in command of both written and verbal in English and German.